Levels of 8-isoprostane and advanced oxidation protein products in relation to sperm count and motility
Main Article Content
Keywords
Oxidative stress, 8-isoprostanes, AOPP, oligozoospermia, asthenozoospermia, infertility
Abstract
Background: Oxidative stress is implicated in male infertility, with reactive oxygen species contributing to sperm dysfunction. Among oxidative stress markers, 8-isoprostanes (8-isoP) and advanced oxidation protein products (AOPP) serve as indicators of lipid peroxidation and protein oxidation, respectively. However, their relationship with specific sperm abnormalities remains unclear. Aim: This study investigates the oxidative stress markers 8-isoprostane (8-isoP) and advanced oxidation protein products (AOPP) across different semen profiles and explores their correlation with sperm count and motility to evaluate their potential as diagnostic biomarkers in male infertility. Methods: A cross-sectional study was conducted on male partners of infertile couples between May 2024 and February 2025. Subjects were categorized into four groups based on semen analysis: normozoospermia (control), oligozoospermia, asthenozoospermia, and azoospermia. Seminal plasma levels of 8-isoP and AOPP were measured using sandwich ELISA kits, and results were compared among the groups. Results: Levels of 8-isoprostanes (8-isoP) and advanced oxidation protein products (AOPP) were significantly elevated in the asthenozoospermia group. In the azoospermia group, AOPP levels showed a significant increase, while 8-isoP exhibited a near-significant rise compared to the control. In contrast, the oligozoospermia group showed no significant increase in either marker. Conclusions: Although both markers increased in asthenozoospermia and azoospermia, AOPP showed greater sensitivity, highlighting protein oxidation’s role in severe sperm dysfunction. The oligospermic group showed no increase in both markers, indicating that isolated reduction in sperm count is unlikely to be caused by oxidative stress.
References
2. Gelbaya TA, Potdar N, Jeve YB, Nardo LG. Definition and epidemiology of unexplained infertility. Obstet Gynecol Surv. 2014;69(2):109–115.
3. Agarwal A, Virk G, Ong C, du Plessis SS. Effect of oxidative stress on male reproduction. World J Mens Health. 2014;32(1):1–17.
4. Gudeloglu A, Brahmbhatt J, Parekattil S. Definitions and epidemiology of unexplained male infertility. In: Schattman GL, Esteves SC, Agarwal A, editors. Unexplained infertility: pathophysiology, evaluation, and treatment. New York: Springer; 2015. p. 15–30.
5. Evans EPP, Scholten JTM, Mzyk A, et al. Male subfertility and oxidative stress. Redox Biol. 2021;46:102071.
6. Bisht S, Faiq M, Tolahunase M, Dada R. Oxidative stress and male infertility. Nat Rev Urol. 2017;14(8):470–485.
7. Takalani NB, Monageng EM, Mohlala K, et al. Role of oxidative stress in male infertility. Reprod Fertil. 2023;4(3):e230024.
8. Janiszewska E, Kokot I, Kmieciak A, et al. Associations between seminal plasma advanced oxidation protein products and redox-related biochemical parameters in infertile men. Cells. 2022;11(22):3667.
9. Signorini C, Moretti E, Collodel G. Role of isoprostanes in human male infertility. Syst Biol Reprod Med. 2020;66(5):291–299.
10. Finelli R, Leisegang K, Kandil H, Agarwal A. Oxidative stress in the pathogenesis and management of varicocele. World J Mens Health. 2022;40(1):87–103.
11. Schubert B, Badiou M, Force A. Computer-aided sperm analysis: a key player in routine sperm assessment. Andrologia. 2019;51(10):e13417.
12. Nowicka-Bauer K, Nixon B. Molecular changes induced by oxidative stress that impair human sperm motility. Antioxidants (Basel). 2020;9(2):134.
13. Wang Y, Fu X, Li H. Mechanisms of oxidative stress-induced sperm dysfunction. Front Endocrinol (Lausanne). 2025;16:1520835.
14. Kurkowska W, Bogacz A, Janiszewska M, et al. Oxidative stress is associated with reduced sperm motility in normal semen. Am J Mens Health. 2020;14(5):1557988320939731.
15. Alahmar AT. Role of oxidative stress in male infertility: an updated review. J Hum Reprod Sci. 2019;12(1):4–18.
16. Hussain T, Kandeel M, Metwally E, et al. Harmful effects of oxidative stress on male fertility: mechanistic insights. Front Endocrinol (Lausanne). 2023;14:1070692.
17. Adgent MA, Gebretsadik T, Elaiho CR, et al. Association between prenatal F2-isoprostanes and childhood wheeze/asthma. Free Radic Biol Med. 2022;189:85–90.
18. Kaviarasan S, Muniandy S, Qvist R, Ismail IS. F2-isoprostanes as biomarkers for type 2 diabetes. J Clin Biochem Nutr. 2009;45(1):1–8.
19. Janssen LJ. Isoprostanes: roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol. 2001;280(6):L1067–L1082.
20. Liu Z, Yao X, Jiang W, et al. Advanced oxidation protein products induce neuroinflammation via MAPK–NF-κB signaling. J Neuroinflammation. 2020;17(1):90.
21. Khosrowbeygi A, Zarghami N. Seminal plasma 8-isoprostane levels and sperm quality. Indian J Clin Biochem. 2008;23(1):49–52.
22. Abd Elrahman MM, El Makawy AI, Hassanane MS, et al. Correlation between asthenozoospermia and mitochondrial DNA mutations. J Genet Eng Biotechnol. 2021;19(1):11.
23. Demir M, Ozdem S. Evaluation of total antioxidant capacity in human seminal plasma. Int J Med Biochem. 2022;5(1):54–59.
24. Agarwal A, Mulgund A, Sharma R, Sabanegh E. Mechanisms of oligozoospermia: an oxidative stress perspective. Syst Biol Reprod Med. 2014;60(4):206–216.
25. Aitken RJ, Baker MA. Genetics and oxidative stress in male infertility: a unifying hypothesis. Front Endocrinol (Lausanne). 2020;11:581838.
26. Cito G, Becatti M, Natali A, et al. Redox status assessment in non-obstructive azoospermia. Andrology. 2020;8(2):364–371.
27. Kratz EM, Piwowar A, Zeman M, et al. Advanced oxidation protein products and melatonin levels in seminal plasma. Reprod Fertil Dev. 2016;28(4):507–515.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Sherwan Ferman Salih, College of Medicine, University of Duhok, Duhok, Iraq.
.